ATR inhibition augments the efficacy of lurbinectedin in small‐cell lung cancer is a research paper published in EMBO Molecular Medicine (2023). On theSindex it has a DataRank of 0.944. It has been cited 28 times, with 22 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.505
From this paper's citation signal
Citation Network Contribution
0.439
From 18 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 22 citers.
HHS | NIH | National Cancer Institute
Grant: ZIA BC 011793
FWCI
3.29
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals